Corteva (NYSE:CTVA) Price Target Raised to $88.00

Corteva (NYSE:CTVA) had its target price increased by UBS Group from $80.00 to $88.00 in a research note published on Thursday morning, Marketbeat.com reports. The brokerage currently has a neutral rating on the stock.

Several other research firms have also issued reports on CTVA. Wells Fargo & Company upped their target price on Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Citigroup upped their target price on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft upped their target price on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Wolfe Research upped their target price on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Finally, Royal Bank Of Canada upped their target price on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $83.57.

Corteva Stock Performance

Shares of Corteva stock opened at $83.86 on Thursday. The company has a market cap of $56.30 billion, a PE ratio of 53.08, a price-to-earnings-growth ratio of 2.86 and a beta of 0.68. Corteva has a 52 week low of $57.00 and a 52 week high of $85.63. The business has a 50 day moving average price of $78.74 and a 200-day moving average price of $70.58. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts anticipate that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were paid a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.15% of the company’s stock.

Hedge Funds Weigh In On Corteva

Several institutional investors have recently bought and sold shares of the company. Chilton Capital Management LLC lifted its position in shares of Corteva by 18.1% during the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock worth $30,119,000 after acquiring an additional 68,380 shares in the last quarter. Drummond Knight Asset Management Pty Ltd purchased a new stake in shares of Corteva during the fourth quarter worth $25,713,000. TriaGen Wealth Management LLC purchased a new stake in shares of Corteva during the third quarter worth $4,284,000. Truist Financial Corp lifted its position in shares of Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after acquiring an additional 13,910 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its position in shares of Corteva by 4.5% during the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock worth $37,290,000 after acquiring an additional 23,548 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.